SACCARDI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.379
EU - Europa 2.105
AS - Asia 1.980
SA - Sud America 214
AF - Africa 79
OC - Oceania 18
Totale 7.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.337
RU - Federazione Russa 1.003
SG - Singapore 588
CN - Cina 520
IT - Italia 263
HK - Hong Kong 236
IE - Irlanda 220
VN - Vietnam 174
BR - Brasile 172
KR - Corea 164
SE - Svezia 161
PL - Polonia 96
IN - India 90
FR - Francia 82
DE - Germania 70
FI - Finlandia 63
GB - Regno Unito 43
JO - Giordania 43
CH - Svizzera 39
BD - Bangladesh 34
JP - Giappone 31
IR - Iran 23
CA - Canada 22
ID - Indonesia 18
AU - Australia 17
ES - Italia 17
AR - Argentina 15
EC - Ecuador 14
EG - Egitto 14
MX - Messico 14
NL - Olanda 14
CI - Costa d'Avorio 13
MA - Marocco 13
TR - Turchia 12
NG - Nigeria 11
ZA - Sudafrica 10
CO - Colombia 9
UA - Ucraina 9
KE - Kenya 8
IQ - Iraq 7
PH - Filippine 7
UZ - Uzbekistan 6
PK - Pakistan 5
AZ - Azerbaigian 4
BE - Belgio 4
DZ - Algeria 4
AT - Austria 3
LT - Lituania 3
LV - Lettonia 3
BJ - Benin 2
CL - Cile 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MY - Malesia 2
NP - Nepal 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 7.775
Salva come PNG Salva come JPEG
Città #
Santa Clara 886
Ashburn 445
Singapore 437
Dublin 220
Hong Kong 204
Fairfield 191
Chandler 184
Seoul 163
San Jose 122
Hefei 110
Beijing 107
Warsaw 94
Woodbridge 84
Altamura 71
Lawrence 71
Seattle 70
Cambridge 69
Wilmington 67
Los Angeles 63
Ho Chi Minh City 62
Houston 59
Florence 52
Mumbai 52
Buffalo 49
Lauterbourg 49
Ann Arbor 47
Kent 46
Munich 43
Dallas 42
Princeton 42
Boston 41
The Dalles 38
Hanoi 37
Bern 35
New York 34
Milan 32
Tokyo 31
Moscow 27
Council Bluffs 25
Helsinki 24
Clifton 23
Turku 23
São Paulo 22
Dearborn 19
Shanghai 19
Paris 17
Guangzhou 15
Melbourne 15
Frankfurt am Main 14
Medford 14
Abidjan 13
Jakarta 13
Da Nang 12
San Diego 12
Abuja 11
Redondo Beach 11
Casablanca 10
Chennai 10
Boardman 9
Cairo 9
Falls Church 9
Orem 9
Barcelona 8
Lappeenranta 8
Montreal 8
Yubileyny 8
Bengaluru 7
Norwalk 7
Rome 7
Toronto 7
Biên Hòa 6
Johannesburg 6
London 6
Atlanta 5
Curitiba 5
Denver 5
Dhaka 5
Haiphong 5
Jacksonville 5
Manchester 5
Pune 5
Rio de Janeiro 5
Shenzhen 5
Tehran 5
Thái Bình 5
Amsterdam 4
Andover 4
Ankara 4
Baku 4
Belo Horizonte 4
Brooklyn 4
Brussels 4
Dong Ket 4
Mexico City 4
Nairobi 4
Ninh Bình 4
Ottawa 4
Phoenix 4
Poplar 4
Porto Alegre 4
Totale 5.032
Salva come PNG Salva come JPEG
Nome #
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells 251
Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia ― The scelta trial 245
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/Regeneration. Preclinical Aspects 222
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 211
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 200
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 198
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 191
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients 185
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 184
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 182
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 182
MSCs seeded on bioengineered scaffolds improve skin wound healing in rats. 181
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 181
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation 178
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 170
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells 168
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 168
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 163
Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium. 158
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 158
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 155
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis 151
Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience 147
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 146
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 144
The effects of Exendin-4 on bone marrow-derived mesenchymal cells. 143
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 142
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 140
Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience 133
Mesenchymal Stem Cells and Autoimmune Diseases: The Case of Multiple Sclerosis 132
CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis 132
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 129
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update 129
Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen 128
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis 127
Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. 124
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 122
GENE EXPRESSION ANALYSIS OF PBMNC FROM MS PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT) 118
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor 118
Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis 116
Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology 113
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 112
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis 112
The role of chemotherapy in hematopoietic stem cell transplantation for autoimmune disorders: From lymphoablative to myeloablative conditioning protocols 106
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 106
Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis 106
DIFFERENCES IN MSCS IP-10 PRODUCTION BETWEEN MS PATIENTS AND HEALTHY DONORS 105
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 104
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 103
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis? 102
Panel Session Report: Multiple Sclerosis 88
Long term outcomes after autologous hematopoietic stem cell transplantation for treatment of MS 85
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT 83
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation 76
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party 22
Totale 7.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022280 3 32 12 24 17 5 8 32 15 6 42 84
2022/2023899 57 197 61 35 60 142 117 61 92 0 35 42
2023/2024472 10 61 50 31 38 57 22 85 9 29 52 28
2024/20252.708 120 290 171 463 698 393 55 126 114 49 98 131
2025/20262.694 361 437 284 268 341 109 317 114 167 185 111 0
Totale 7.875